As can be seen in Figure 5, pre-treatment with neither type I (IFN-β) nor type III (IFN-λ) IFN was found to be fully protective against viral infection in the ZIKV-susceptible HASTR/ci35 astrocytes (Figure 5 and Figure S2). Here, IFNB1 is linked to viral infectious disease.